Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 14 May 2024 21:55:31 +0200Tue, 26 Mar 2024 14:21:00 +0100Human medicines European public assessment report (EPAR): Livtencity, maribavir, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/livtencityHuman medicines European public assessment report (EPAR): Livtencity, maribavir, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/livtencityTue, 26 Mar 2024 14:21:00 +0100Human medicineLivtencity : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5787-en.pdfLivtencity : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5787-en.pdfMon, 05 Feb 2024 14:20:00 +0100Human medicine